P839 Clinical and sociodemographical characteristics of inflammatory bowel disease in Mexico: Multicentric nation-wide study (EPIMEX-IBD)

Yamamoto-Furusho, J.K.; Sarmiento, Alberto Martínez; Toledo-Mauriño, Joel; Bozada‐Gutiérrez, Katya; Bosques-Padilla, Francisco; Martínez-Vazquez, Manuel; Marroquín-Jiménez, V; García-Figueroa, Rosalva; Jaramillo-Buendía, C; Miranda-Cordero, R.M.; Valenzuela-Pérez, Jesús Alonso; Y, Cortés-Aguilar; Jacobo-Karam, J.S.; Bermudez-Villegas, E

doi:10.1093/ecco-jcc/jjx180.966

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 10 , 17 , 21 – 24 , 27 – 30 , 33 In a nationwide study in Mexico, which separated UC extension by age group, pancolitis was the most frequent extension of UC in children (64.4%), adult (62.2%) and elderly (57.7%) patients; distal/proctosigmoiditis was the second most frequent extension in children (22.2%), adult (24.8%) and elderly (26.8%) patients; and left-sided colitis was the least frequent extension in children (13.3%), adult (13.0%) and elderly (15.6%) patients. 27 , 28 In line with this, the highest proportion of patients (43%) had pancolitis in a study in Argentina. 10 Proximal extension developed in 17.4% of patients in Montevideo, Uruguay.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Review of the epidemiology and burden of ulcerative colitis in Latin America

Kotze

Steinwurz

Francisconi

et al. 2020

Therap Adv Gastroenterol

View full text Add to dashboard Cite

The incidence and prevalence of ulcerative colitis (UC) has been reported to be rising in newly industrialised regions, such as Latin America. Here, we review data from published studies reporting demographics and clinical aspects of UC in Latin America to further understand epidemiology and disease burden. The incidence and prevalence of UC in Latin America varied between regions and studies, ranging between 0.04 to 8.00/100,000 and 0.23 to 76.1/100,000, respectively, and generally increased over the period from 1986 to 2015. The majority of patients with UC were female (53.6–72.6%) and urban residents (77.8–97.4%). Extraintestinal manifestations were reported in approximately 26–89.4% of patients. Use of biologic therapies was generally low (0.8–16.2%), with the exception of Mato Grosso do Sul, Brazil, with a greater proportion of patients tending to receive 5-aminosalicylates, immunosuppressants or corticosteroids; colectomy rates varied between studies (1.5–22%). A high proportion of patients had moderate to severe UC (45.9–73.0%) and, in 11 of 19 studies, the greatest proportion of patients had extensive disease (pancolitis). Colorectal cancer (0–1.7%) and mortality rates (0–7.6%) were low. This evaluation of published studies may influence therapeutic approaches and the development of strategies to improve healthcare access and patient outcomes, although further high-quality studies are required in patients with UC in Latin America.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Multicentre 25 Public health department records (multicentre) 8951 Colombia Nationwide 26 Database (insurance claims) − Mexico Nationwide 27,28 Clinics (multicentre) 2073 only, and 4 articles that reported both incidence and prevalence rates.…”

mentioning

confidence: 99%